Additional mutation analysis was performed on the biopsy taken at diagnosis and revealed a PDGFRα exon 18 (NM_006206.5: c.2527_2538del; p.(I843_D846del)) mutation (the average coverage is ∼2500 reads in tumor DNA with neoplastic content of 95%). The gene discussed is PDGFRA; the disease is neoplasm.